We provide our clients with multiplexed cytokine measurement for monitoring therapies targeting or promoting immune activity

We assay phase 2 and 3 clinical study blood and other body fluid samples for changes in a wide range of cytokines, chemokines and immune-inflammatory markers.

This not only provides demonstration of mechanism of action of immunoactive therapies for regulatory purposes, but also monitoring of cytokine release syndrome in immunogenicity.

This activity incorporates both Aeirtec's patented and proprietary methods to achieve extreme assay sensitivity and precision.

The graph on the right provides an example of a customised panel designed through discussion with the client.